FADD recruits regulatory proteins of the NF-κB and MAPK pathways, thereby promoting proliferation and the cell cycle71, and our results and HPA data demonstrate that indicating that FADD is a poor prognostic marker of lung cancer. The gene discussed is FADD; the disease is lung carcinoma.